News Daily News AHA/ACC Report Recommends 10 Measures to Prevent Sudden Cardiac Death Leah Lawrence December 23, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Daily News Updated ACTION-GWTG Risk Score Aims to Better Predict In-Hospital Mortality After Acute MI Yael L. Maxwell August 03, 2016
News Daily News New A-fib Performance and Quality Measures Emphasize Shared Decision-Making, Inpatient and Outpatient Care Michael O'Riordan June 29, 2016
News Conference News EuroPCR 2016 Valvular Interventions for the Asymptomatic and Low Risk: Coming Soon to a Cath Lab Near You? Yael L. Maxwell May 20, 2016
News Daily News Mechanical Circulatory Support in High-Risk PCI: A Guide to Which, When, Who, and How Todd Neale May 05, 2016
News Daily News Suboptimal Care for Women With CAD Linked to Higher Long-Term Mortality Caitlin E. Cox February 28, 2016
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015
News Industry News DC Devices Completes Enrollment In Clinical Trial Of The First Transcatheter Device To Treat Diastolic Heart Failure; Announces Name Change To Corvia Medical June 22, 2015
News Industry News Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction June 22, 2015
News Industry News Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy June 16, 2015
News Daily News Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery Caitlin E. Cox June 15, 2015
News Industry News Juventas Therapeutics Presents New 12-Month Data Demonstrating Single Administration of JVS-100 Improves Cardiac and Clinical Status in Patients with Severe Ischemic Heart Failure One Year After Treat May 26, 2015
News Industry News CVRx® Barostim Therapy® for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference May 26, 2015
Presentation TCT 2012 Validation of Age, Creatinine, and Ejection Fraction Score As a Risk Assessment Tool In Patients Undergoing Stent Implantation During Percutaneous Coronary Intervention. A... Presenter: Hiroya Nambu, Faith Selzer, Suresh Mulukutla, Joon S. Lee, David O. Williams, Sherryl Kelsey, Kevin E. Kip, Oscar C. Marroquin January 03, 2012